Research Status of Magnetic Resonance Spectroscopy for the Detection of Metabolites in Brain

doi:10.12337/zgkqjxjyzz.2023.06.001

Chinese Journal of Stomatological Continuing Education ›› 2023, Vol. 26 ›› Issue (6): 433-437.DOI: 10.12337/zgkqjxjyzz.2023.06.001

Research Status of Magnetic Resonance Spectroscopy for the Detection of Metabolites in Brain

Fengwei Zhang^*

Department of Anesthesiology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

Online:2023-11-30 Published:2024-03-13
Contact: ^*Fengwei Zhang. Tel: 17852061788. Email: zhangfwei98@163.com. Address: Department of Anesthesiology, 9th Floor, Building 1, Shanghai Ninth Hospital, 639 Manufacturing Bureau Road, Huangpu District, Shanghai 200011, P.R. China.

Abstract

Abstract: Magnetic resonance spectroscopy, is a non-invasive imaging method to detect metabolite content in the brain, plays an important role in the clinical assessment of neurological diseases. Abnormal metabolite levels may cause neurological diseases. This paper reviews the research status and some clinical applications of magnetic resonance spectroscopy in the detection of metabolites in brain.

Key words: magnetic resonance spectrum, brain metabolites, diagnosis of neurological diseases, general anesthesia, postoperative cognitive dysfunction

Fengwei Zhang. Research Status of Magnetic Resonance Spectroscopy for the Detection of Metabolites in Brain[J]. Chinese Journal of Stomatological Continuing Education, 2023, 26(6): 433-437.

References

[1] Rundshagen I.Postoperative cognitive dysfunction[J]. Dtsch Arztebl Int. 2014; 111(8):119-125.
[2] Andersen JV, Schousboe A, Verkhratsky A.Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: Integration of the glutamate/GABA-glutamine cycle[J]. Prog Neurobiol. 2022; 217:102331.
[3] Henning A.Proton and multinuclear magnetic resonance spectroscopy in the human brain at ultra-high field strength: A review[J]. Neuroimage. 2018; 168:181-198.
[4] Tumati S, Martens S, Aleman A.Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis[J]. Neurosci Biobehav Rev. 2013; 37(10 Pt 2):2571-2586.
[5] Fujima N, Carlota Andreu-Arasa V, Barest GD, et al. Magnetic Resonance Spectroscopy of the Head and Neck: Principles, Applications, and Challenges[J]. Neuroimaging Clin N Am. 2020; 30(3):283-293.
[6] García-Figueiras R, Baleato-González S, Padhani AR, et al.Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer[J]? Diagn Interv Radiol. 2016; 22(1):75-89.
[7] Rhodes CJ.Magnetic resonance spectroscopy[J]. Sci Prog. 2017; 100(3):241-292.
[8] Haga KK, Khor YP, Farrall A, et al.A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging. Neurobiol Aging[J]. 2009; 30(3):353-363.
[9] Hellström J, Romanos Zapata R, Libard S, et al.The value of magnetic resonance spectroscopy as a supplement to MRI of the brain in a clinical setting[J]. PLoS One. 2018; 13(11):e0207336.
[10] Soares DP, Law M. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications[J]. Clin Radiol.2009 Jan; 64(1):12-21.
[11] Bertholdo D, Watcharakorn A, Castillo M.Brain proton magnetic resonance spectroscopy: introduction and overview[J]. Neuroimaging Clin N Am. 2013; 23(3):359-380.
[12] Bolan PJ.Magnetic resonance spectroscopy of the breast: current status[J]. Magn Reson Imaging Clin N Am. 2013; 21(3):625-639.
[13] Chabert J, Allauze E, Pereira B, et al.Glutamatergic and N-Acetylaspartate Metabolites in Bipolar Disorder: A Systematic Review and Meta-Analysis of Proton Magnetic Resonance Spectroscopy Studies[J]. Int J Mol Sci. 2022; 23(16):8974.
[14] La PL, Joyce JM, Bell TK, et al.Brain metabolites measured with magnetic resonance spectroscopy in pediatric concussion and orthopedic injury: An Advancing Concussion Assessment in Pediatrics (A-CAP) study[J]. Hum Brain Mapp. 2023; 44(6):2493-2508.
[15] Veeramuthu V, Seow P, Narayanan V, et al.Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI): An In Vivo Proton Magnetic Resonance Spectroscopy (1H-MRS) Study[J]. Acad Radiol. 2018; 25(9):1167-1177.
[16] Guo Z, Liu X, Hou H, et al.(1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer’s disease[J]. Compr Psychiatry. 2016; 69:179-85.
[17] Rodríguez-Nieto G, Levin O, Hermans L, et al.Organization of neurochemical interactions in young and older brains as revealed with a network approach: Evidence from proton magnetic resonance spectroscopy (1H-MRS)[J]. Neuroimage. 2023; 266:119830.
[18] Rietzler A, Steiger R, Mangesius S, et al.Energy metabolism measured by 31P magnetic resonance spectroscopy in the healthy human brain[J]. J Neuroradiol. 2022; 49(5):370-379.
[19] Meyerhoff DJ.Brain proton magnetic resonance spectroscopy of alcohol use disorders[J]. Handb Clin Neurol. 2014; 125:313-337.
[20] Bittšanský M, Výbohová D, Dobrota D.Proton magnetic resonance spectroscopy and its diagnostically important metabolites in the brain[J]. Gen Physiol Biophys. 2012; 31(1):101-112.
[21] Lin X, Chen Y, Zhang P, et al.The potential mechanism of postoperative cognitive dysfunction in older people[J]. Exp Gerontol. 2020; 130:110791.
[22] Andersen JV, Christensen SK, Westi EW, et al.Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer’s disease[J]. Neurobiol Dis. 2021; 148:105198.
[23] McCarthy L, Verma G, Hangel G, et al. Application of 7T MRS to High-Grade Gliomas[J]. AJNR Am J Neuroradiol. 2022; 43(10):1378-1395.
[24] Nummela AJ, Laaksonen LT, Laitio TT, et al.Effects of dexmedetomidine, propofol, sevoflurane and S-ketamine on the human metabolome: A randomised trial using nuclear magnetic resonance spectroscopy[J]. Eur J Anaesthesiol. 2022; 39(6):521-532.
[25] Boretius S, Tammer R, Michaelis T, et al.Halogenated volatile anesthetics alter brain metabolism as revealed by proton magnetic resonance spectroscopy of mice in vivo[J]. Neuroimage. 2013; 69:244-255.
[26] Söbbeler FJ, Carrera I, Pasloske K, et al.Effects of isoflurane, sevoflurane, propofol and alfaxalone on brain metabolism in dogs assessed by proton magnetic resonance spectroscopy (1H MRS)[J]. BMC Vet Res. 2018; 14(1):69.

Research Status of Magnetic Resonance Spectroscopy for the Detection of Metabolites in Brain

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 1

Recommended Articles

Metrics

Comments